# FDA Inspection 1258924 - Vitalant - January 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/vitalant/388e0ae6-101f-4871-a106-7c8f9c8b0bcc
Source feed: FDA_Inspections

> FDA Inspection 1258924 for Vitalant on January 17, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1258924
- Company Name: Vitalant
- Inspection Date: 2025-01-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258924 - 2025-01-17](https://www.keypedia.com/records/fda_inspections/vitalant/be289a83-0594-422a-b6d3-4d828c215879)
- [FDA Inspection 1174688 - 2022-06-30](https://www.keypedia.com/records/fda_inspections/vitalant/4497bc12-8684-4b86-be8e-cb4f24905750)
- [FDA Inspection 1033940 - 2017-11-29](https://www.keypedia.com/records/fda_inspections/vitalant/9f58179d-4a2b-453a-8443-278c65b11257)
- [FDA Inspection 968735 - 2016-02-24](https://www.keypedia.com/records/fda_inspections/vitalant/a5882ed0-4d06-4129-9e28-5d00a1c04e03)
- [FDA Inspection 865478 - 2014-02-05](https://www.keypedia.com/records/fda_inspections/vitalant/f5bce8f3-36d5-437e-a83c-5844c4fcacf3)

Company: https://www.keypedia.com/companies/vitalant/5cd6c450-2944-4ebc-8d3f-1dd7f4c510e3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d